| Bioactivity | OncoFAP-GlyPro-MMAF is a Drug-Linker Conjugate for ADC with potent antitumor activity. OncoFAP-GlyPro-MMAF consists of Monomethylauristatin F (HY-15579) and a linker. OncoFAP-GlyPro-MMAF can be used for synthesis of ADCs[1]. |
| Formula | C102H140F2N20O28S |
| Molar Mass | 2164.38 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bocci M, et al. Delivery of Monomethyl Auristatin F to the Tumor Microenvironment with Noninternalizing Fibroblast Activation Protein-Cleavable Small Molecule-Drug Conjugates Elicits Potent In Vivo Anticancer Activity. Bioconjug Chem. 2025 Jan 15;36(1):15-19. |
OncoFAP-GlyPro-MMAF
CAS: F: C102H140F2N20O28S W: 2164.38
OncoFAP-GlyPro-MMAF is a Drug-Linker Conjugate for ADC with potent antitumor activity. OncoFAP-GlyPro-MMAF consists of M
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.